Characterization of different regimens for initiating anagrelide in patients with essential thrombocythemia who are intolerant or refractory to their current cytoreductive therapy: results from the multicenter FOX study of 177 patients in France.

Français
Author : 
Rey, J ; Viallard, JF ; Keddad, K ; Smith, J ; Wilde, P ; Kiladjian, JJ
Newspaper edition : 
Eur. J. Haematol. - Année 2014 - Volume 92 - Page 127-36 - PMID 24118452